{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T01:38:51Z","timestamp":1794533931935,"version":"4.9.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,7,14]],"date-time":"2023-07-14T00:00:00Z","timestamp":1689292800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,7,14]],"date-time":"2023-07-14T00:00:00Z","timestamp":1689292800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100010552","name":"Departament de Salut, Generalitat de Catalunya","doi-asserted-by":"publisher","award":["SLT002\/16\/00095"],"award-info":[{"award-number":["SLT002\/16\/00095"]}],"id":[{"id":"10.13039\/501100010552","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Knowledge of the characteristics of first-ever cardiovascular events in type 1 diabetes may impact primary prevention strategies. This study describes the first-ever manifestation of cardiovascular disease (CVD) in patients with type 1 diabetes (T1D) in Catalonia (Spain) and evaluates differences according to age and sex.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Retrospective cohort study of patients with T1D\u2009&gt;\u200930\u00a0years without CVD before 2010 registered in the SIDIAP database. The occurrence of a first cardiovascular event up to the end of 2016, the type of CV event and associations with baseline characteristics were analysed.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Of 8412 patients, 884 suffered a first CV event (incidence rate 1.62 per 100 persons-years). Overall, peripheral vascular disease (39.5%) was the most frequent event. We observed a higher proportion of heart failure in women (21.7%) than in men (10.1%). In women, heart failure was the most frequent event in those\u2009&gt;\u200965\u00a0years (40.5%). Decreased glomerular filtration rate (hazard ratio [HR] 5.42 [95% CI 4.32;6.80]), elevated albumin\/creatinine ratio (HR 3.39 [95% CI [2.47;4.66], microvascular complications (HR 3.27 [95% CI 2.85;3.75]), and hypertension (HR 3.21 [95% CI [2.80;3.67]) were most strongly associated with a first CV event. HbA1c\u2009&gt;\u20097.0% was associated with incident CVD only in patients aged\u2009&lt;\u200955\/60\u00a0years.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Peripheral artery disease in the whole cohort, and heart failure in elder subjects are the most frequent first-ever CVD events in T1D in our region. These findings deserve to be taken into account when considering primary prevention measures and when estimating CV risk in people with T1D.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12933-023-01917-1","type":"journal-article","created":{"date-parts":[[2023,7,14]],"date-time":"2023-07-14T19:01:46Z","timestamp":1689361306000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Epidemiology of the first-ever cardiovascular event in people with type 1 diabetes: a retrospective cohort population-based study in Catalonia"],"prefix":"10.1186","volume":"22","author":[{"given":"Gabriel","family":"Gim\u00e9nez-P\u00e9rez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara","family":"Vi\u00f1als","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manel","family":"Mata-Cases","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bogdan","family":"Vlacho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordi","family":"Real","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josep","family":"Franch-Nadal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilio","family":"Ortega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D\u00eddac","family":"Mauricio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,7,14]]},"reference":[{"key":"1917_CR1","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1056\/nejmoa1408214","volume":"371","author":"M Lind","year":"2014","unstructured":"Lind M, Svensson A-M, Kosiborod M, Gudbj\u00f6rnsdottir S, Pivodic A, Wedel H, Dahlqvist S, Clements M, Rosengren A. Glycemic control and excess mortality in type 1 diabetes. N Engl J Med. 2014;371:1972\u201382. https:\/\/doi.org\/10.1056\/nejmoa1408214.","journal-title":"N Engl J Med"},{"key":"1917_CR2","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1007\/s00125-005-0120-4","volume":"49","author":"SS Soedamah-Muthu","year":"2006","unstructured":"Soedamah-Muthu SS, Fuller JH, Mulnier HE, Raleigh VS, Lawrenson RA, Colhoun HM. All-cause mortality rates in patients with type 1 diabetes mellitus compared with a non-diabetic population from the UK general practice research database, 1992\u20131999. Diabetologia. 2006;49:660\u20136. https:\/\/doi.org\/10.1007\/s00125-005-0120-4.","journal-title":"Diabetologia"},{"key":"1917_CR3","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1001\/jama.2014.16425","volume":"313","author":"SJ Livingstone","year":"2015","unstructured":"Livingstone SJ, Levin D, Looker HC, Lindsay RS, Wild SH, Joss N, Leese G, Leslie P, McCrimmon RJ, Metcalfe W, McKnight JA, Morris AD, Pearson DWM, Petrie JR, Philip S, Sattar NA, Traynor JP, Colhoun HM. Estimated life expectancy in a Scottish cohort with type 1 diabetes, 2008\u20132010. JAMA. 2015;313:37\u201344. https:\/\/doi.org\/10.1001\/jama.2014.16425.","journal-title":"JAMA"},{"key":"1917_CR4","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1056\/nejmoa1608664","volume":"376","author":"A Rawshani","year":"2017","unstructured":"Rawshani A, Rawshani A, Franz\u00e9n S, Eliasson B, Svensson A-M, Miftaraj M, McGuire DK, Sattar N, Rosengren A, Gudbj\u00f6rnsdottir S. Mortality and cardiovascular disease in type 1 and type 2 diabetes. N Engl J Med. 2017;376:1407\u201318. https:\/\/doi.org\/10.1056\/nejmoa1608664.","journal-title":"N Engl J Med"},{"key":"1917_CR5","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.2337\/dc15-2308","volume":"39","author":"JL Harding","year":"2016","unstructured":"Harding JL, Shaw JE, Peeters A, Davidson S, Magliano DJ. Age-specific trends from 2000\u20132011 in all-cause and cause-specific mortality in type 1 and type 2 diabetes: a cohort study of more than one million people. Diabetes Care. 2016;39:1018\u201326. https:\/\/doi.org\/10.2337\/dc15-2308.","journal-title":"Diabetes Care"},{"key":"1917_CR6","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/S0140-6736(18)31506-X","volume":"392","author":"A Rawshani","year":"2018","unstructured":"Rawshani A, Sattar N, Franz\u00e9n S, Rawshani A, Hattersley AT, Svensson AM, Eliasson B, Gudbj\u00f6rnsdottir S. Excess mortality and cardiovascular disease in young adults with type 1 diabetes in relation to age at onset: a nationwide, register-based cohort study. Lancet. 2018;392:477\u201386. https:\/\/doi.org\/10.1016\/S0140-6736(18)31506-X.","journal-title":"Lancet"},{"key":"1917_CR7","doi-asserted-by":"publisher","first-page":"1900","DOI":"10.1161\/CIRCULATIONAHA.118.037454","volume":"139","author":"A Rawshani","year":"2019","unstructured":"Rawshani A, Rawshani A, Sattar N, Franz\u00e9n S, Mcguire DK, Eliasson B, Svensson AM, Zethelius B, Miftaraj M, Rosengren A, Gudbj\u00f6rnsdottir S. Relative prognostic importance and optimal levels of risk factors for mortality and cardiovascular outcomes in type 1 diabetes mellitus. Circulation. 2019;139:1900\u201312. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.118.037454.","journal-title":"Circulation"},{"key":"1917_CR8","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/S2213-8587(14)70248-7","volume":"3","author":"RR Huxley","year":"2015","unstructured":"Huxley RR, Peters SAE, Mishra GD, Woodward M. Risk of all-cause mortality and vascular events in women versus men with type 1 diabetes: a systematic review and meta-analysis. Lancet Diabetes Endocrinol. 2015;3:198\u2013206. https:\/\/doi.org\/10.1016\/S2213-8587(14)70248-7.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"1917_CR9","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1161\/CIRCULATIONAHA.116.025961","volume":"135","author":"A Rawshani","year":"2017","unstructured":"Rawshani A, Rawshani A, Franz\u00e9n S, Eliasson B, Svensson A-M, Miftaraj M, McGuire DK, Sattar N, Rosengren A, Gudbj\u00f6rnsdottir S. Range of risk factor levels. Circulation. 2017;135:1522\u201331. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.116.025961.","journal-title":"Circulation"},{"key":"1917_CR10","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.2337\/db15-1517","volume":"65","author":"DM Nathan","year":"2016","unstructured":"Nathan DM, Bebu I, Braffett BH, Lachin JM, Orchard TJ, Cowie CC, Lopes-Virella M, Schutta M. Risk factors for cardiovascular disease in type 1 diabetes. Diabetes. 2016;65:1370\u20139. https:\/\/doi.org\/10.2337\/db15-1517.","journal-title":"Diabetes"},{"key":"1917_CR11","doi-asserted-by":"publisher","first-page":"867","DOI":"10.2337\/dc19-2292","volume":"43","author":"I Bebu","year":"2020","unstructured":"Bebu I, Schade D, Braffett B, Kosiborod M, Lopes-Virella M, Soliman EZ, Herman WH, Bluemke DA, Wallia A, Orchard T, Lachin JM. Risk factors for first and subsequent CVD events in type 1 diabetes: the DCCT\/EDIC study. Diabetes Care. 2020;43:867\u201374. https:\/\/doi.org\/10.2337\/dc19-2292.","journal-title":"Diabetes Care"},{"key":"1917_CR12","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.3390\/jcm10071536","volume":"10","author":"G Gimenez-Perez","year":"2021","unstructured":"Gimenez-Perez G, Franch-Nadal J, Ortega E, Mata-Cases M, Goday A, Real J, Rodriguez A, Vlacho B, Mauricio D, Barcelo A. Clinical medicine clinical characteristics and degree of glycemic and cardiovascular risk factor control in patients with type 1 diabetes in Catalonia (Spain). J Clin Med. 2021;10:1536. https:\/\/doi.org\/10.3390\/jcm10071536.","journal-title":"J Clin Med"},{"key":"1917_CR13","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyac068","author":"M Recalde","year":"2022","unstructured":"Recalde M, Rodr\u00edguez C, Burn E, Far M, Garc\u00eda D, Carrere-Molina J, Ben\u00edtez M, Moleras A, Pistillo A, Bol\u00edbar B, Arag\u00f3n M, Duarte-Salles T. Data resource profile: the information system for research in primary care (SIDIAP). Int J Epidemiol. 2022. https:\/\/doi.org\/10.1093\/ije\/dyac068.","journal-title":"Int J Epidemiol"},{"key":"1917_CR14","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1007\/s00125-022-05659-9","volume":"65","author":"PLD Ruiz","year":"2022","unstructured":"Ruiz PLD, Chen L, Morton JI, Salim A, Carstensen B, Gregg EW, Pavkov ME, Mata-Cases M, Mauricio D, Nichols GA, Pildava S, Read SH, Wild SH, Shaw JE, Magliano DJ. Mortality trends in type 1 diabetes: a multicountry analysis of six population-based cohorts. Diabetologia. 2022;65:964\u201372. https:\/\/doi.org\/10.1007\/s00125-022-05659-9.","journal-title":"Diabetologia"},{"key":"1917_CR15","doi-asserted-by":"publisher","first-page":"810757","DOI":"10.3389\/fendo.2021.810757","volume":"12","author":"M Mata-Cases","year":"2022","unstructured":"Mata-Cases M, Vlacho B, Real J, Puig-Treserra R, Bund\u00f3 M, Franch-Nadal J, Mauricio D. Trends in the degree of control and treatment of cardiovascular risk factors in people with type 2 diabetes in a primary care setting in catalonia during 2007\u20132018. Front Endocrinol (Lausanne). 2022;12:810757. https:\/\/doi.org\/10.3389\/fendo.2021.810757.","journal-title":"Front Endocrinol (Lausanne)."},{"key":"1917_CR16","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/S2213-8587(21)00327-2","volume":"10","author":"DJ Magliano","year":"2022","unstructured":"Magliano DJ, Chen L, Carstensen B, Gregg EW, Pavkov ME, Salim A, Andes LJ, Balicer R, Baviera M, Chan JCN, Cheng YJ, Gardiner H, Gulseth HL, Gurevicius R, Ha KH, Jermendy G, Kim DJ, Kiss Z, Leventer-Roberts M, Lin CY, Luk AOY, Ma S, Mata-Cases M, Mauricio D, Nichols GA, Pildava S, Porath A, Read SH, Robitaille C, Roncaglioni MC, Lopez-Doriga Ruiz P, Wang KL, Wild SH, Yekutiel N, Shaw JE. Trends in all-cause mortality among people with diagnosed diabetes in high-income settings: a multicountry analysis of aggregate data. Lancet Diabetes Endocrinol. 2022;10:112\u20139. https:\/\/doi.org\/10.1016\/S2213-8587(21)00327-2.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"1917_CR17","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1157\/13123961","volume":"22","author":"MF Dom\u00ednguez-Berj\u00f3n","year":"2008","unstructured":"Dom\u00ednguez-Berj\u00f3n MF, Borrell C, Cano-Serral G, Esnaola S, Nolasco A, Pasar\u00edn MI, Ramis R, Saurina C, Escolar-Pujolar A. Constructing a deprivation index based on census data in large Spanish cities (the MEDEA project). Gac Sanit. 2008;22:179\u201387. https:\/\/doi.org\/10.1157\/13123961.","journal-title":"Gac Sanit"},{"key":"1917_CR18","first-page":"19","volume":"33","author":"A Ruiz-Garc\u00eda","year":"2021","unstructured":"Ruiz-Garc\u00eda A, Arranz-Mart\u00ednez E, Garc\u00eda-Fern\u00e1ndez ME, Cabrera-V\u00e9lez R, Garc\u00eda-Pliego RA, Morales-Cobos LE, Sanz-Pozo B, G\u00f3mez-D\u00edaz E, Rodr\u00edguez-de-Mingo E, Rico-P\u00e9rez MR, Miguel\u00e1\u00f1ez-Valero A, Calder\u00edn-Morales MP, Sand\u00edn-de-Vega E, Hombrados-Gonzalo MP, Luna-Ram\u00edrez S, S\u00e1nchez-Ramos MC, Mora-Casado C, Moreno-Mu\u00f1oz MS, Gonz\u00e1lez-Escobar P, Ruiz-D\u00edaz L, Caballero-Ram\u00edrez N, Zamora-G\u00f3mez MM, Iturmendi-Mart\u00ednez N, Holgado-Catal\u00e1n MS, \u00c1lvarez-Benedicto R, Sanchidri\u00e1-Fern\u00e1ndez PL, Benito-Alonso E, Fern\u00e1ndez-Vicente T, Hern\u00e1ndez-L\u00f3pez RM, Doria-Carlin NA, Fr\u00edas-Vargas MJ, en representaci\u00f3n del Grupo de Investigaci\u00f3n del Estudio SIMETAP. Related cardiometabolic factors and prevalence of low HDL-cholesterol levels and atherogenic dyslipidemia. SIMETAP-AD study. Clin Investig Arterioscler. 2021;33:19\u201329.","journal-title":"Clin Investig Arterioscler."},{"key":"1917_CR19","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1016\/J.MAYOCP.2018.01.014","volume":"93","author":"J Patel","year":"2018","unstructured":"Patel J, Al Rifai M, Scheuner MT, Shea S, Blumenthal RS, Nasir K, Blaha MJ, McEvoy JW. Basic vs more complex definitions of family history in the prediction of coronary heart disease: the multi-ethnic study of atherosclerosis. Mayo Clin Proc. 2018;93:1213\u201323. https:\/\/doi.org\/10.1016\/J.MAYOCP.2018.01.014.","journal-title":"Mayo Clin Proc"},{"key":"1917_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v057.i12","volume":"57","author":"I Subirana","year":"2014","unstructured":"Subirana I, Sanz H, Vila J. Building bivariate tables: the comparegroups package for R. J Stat Softw. 2014;57:1\u201316.","journal-title":"J Stat Softw"},{"key":"1917_CR21","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.1007\/s00125-021-05478-4","volume":"64","author":"SJ McGurnaghan","year":"2021","unstructured":"McGurnaghan SJ, McKeigue PM, Read SH, Franzen S, Svensson AM, Colombo M, Livingstone S, Farran B, Caparrotta TM, Blackbourn LAK, Mellor J, Thoma I, Sattar N, Wild SH, Gudbj\u00f6rnsdottir S, Colhoun HM, Swedish National Diabetes Register and the Scottish Diabetes Research Network Epidemiology Group. Development and validation of a cardiovascular risk prediction model in type 1 diabetes. Diabetologia. 2021;64:2001\u201311. https:\/\/doi.org\/10.1007\/s00125-021-05478-4.","journal-title":"Diabetologia"},{"key":"1917_CR22","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.2337\/dc20-2816","volume":"44","author":"V Harjutsalo","year":"2021","unstructured":"Harjutsalo V, Barlovic DP, Gordin D, Forsblom C, King G, Groop P-H. Presence and determinants of cardiovascular disease and mortality in individuals with type 1 diabetes of long duration: the FinnDiane 50 years of diabetes study. Diabetes Care. 2021;44:1885\u201393. https:\/\/doi.org\/10.2337\/dc20-2816.","journal-title":"Diabetes Care"},{"key":"1917_CR23","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1007\/s00125-022-05698-2","volume":"65","author":"S Soulimane","year":"2022","unstructured":"Soulimane S, Balkau B, Vogtschmidt YD, Toeller M, Fuller JH, Soedamah-Muthu SS. Incident cardiovascular disease by clustering of favourable risk factors in type 1 diabetes: the EURODIAB prospective complications study. Diabetologia. 2022;65:1169\u201378. https:\/\/doi.org\/10.1007\/s00125-022-05698-2.","journal-title":"Diabetologia"},{"key":"1917_CR24","doi-asserted-by":"publisher","first-page":"409","DOI":"10.2337\/db18-0515","volume":"68","author":"RG Miller","year":"2019","unstructured":"Miller RG, Costacou T, Orchard TJ. Risk factor modeling for cardiovascular disease in type 1 diabetes in the Pittsburgh epidemiology of diabetes complications (edc) study: a comparison with the diabetes control and complications trial\/epidemiology of diabetes interventions and complications study (DCCT\/EDIC). Diabetes. 2019;68:409\u201319. https:\/\/doi.org\/10.2337\/db18-0515.","journal-title":"Diabetes"},{"key":"1917_CR25","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.1093\/eurheartj\/ehab309","volume":"42","author":"SCORE2 working group and ESC Cardiovascular risk collaboration","year":"2021","unstructured":"SCORE2 working group and ESC Cardiovascular risk collaboration. SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe. Eur Heart J. 2021;42:2439\u201354. https:\/\/doi.org\/10.1093\/eurheartj\/ehab309.","journal-title":"Eur Heart J"},{"key":"1917_CR26","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1161\/CIRCULATIONAHA.115.018844","volume":"133","author":"D Vistisen","year":"2016","unstructured":"Vistisen D, Andersen GS, Hansen CS, Hulman A, Henriksen JE, Bech-Nielsen H, J\u00f8rgensen ME. Prediction of first cardiovascular disease event in type 1 diabetes mellitus: the steno type 1 risk engine. Circulation. 2016;133:1058\u201366. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.115.018844.","journal-title":"Circulation"},{"key":"1917_CR27","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.2337\/db15-1517","volume":"65","author":"Diabetes Control and Complications Trial\/Epidemiology of Diabetes Interventions and Complications (DCCT\/EDIC) Research Group","year":"2016","unstructured":"Diabetes Control and Complications Trial\/Epidemiology of Diabetes Interventions and Complications (DCCT\/EDIC) Research Group. Risk factors for cardiovascular disease in type 1 diabetes. Diabetes. 2016;65:1370\u20139. https:\/\/doi.org\/10.2337\/db15-1517.","journal-title":"Diabetes"},{"issue":"1","key":"1917_CR28","doi-asserted-by":"publisher","first-page":"S158","DOI":"10.2337\/dc23-S010","volume":"46","author":"NA Sayed","year":"2023","unstructured":"Sayed NA, Aleppo G, Aroda VR, Bannuru RR, Brown FM, Bruemmer D, Collins BS, Das SR, Hilliard ME, Isaacs D, Johnson EL, Kahan S, Khunti K, Kosiborod M, Leon J, Lyons SK, Perry ML, Prahalad P, Pratley RE, Seley JJ, Stanton RC, Gabbay RA, on behalf of the American Diabetes Association. 10. Cardiovascular disease and risk management standards of care in diabetes. Diabetes Care. 2023;46(1):S158\u201390. https:\/\/doi.org\/10.2337\/dc23-S010.","journal-title":"Diabetes Care"},{"key":"1917_CR29","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1056\/2FNEJMoa1901281","volume":"384","author":"CE Lewis","year":"2021","unstructured":"SPRINT Research Group, Lewis CE, Fine LJ, Beddhu S, Cheung AK, Cushman WC, Cutler JA, Evans GW, Johnson KC, Kitzman DW, Oparil S, Rahman M, Reboussin DM, Rocco MV, Sink KM, Snyder JK, Whelton PK, Williamson JD, Wright JT, Ambrosius WT. Final report of a trial of intensive versus standard blood-pressure control. N Engl J Med. 2021;384:1921\u201330. https:\/\/doi.org\/10.1056\/2FNEJMoa1901281.","journal-title":"N Engl J Med"},{"key":"1917_CR30","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1016\/j.mayocp.2022.05.021","volume":"97","author":"FL Norby","year":"2022","unstructured":"Norby FL, Reinier K, Uy-Evanado A, Nichols GA, Stecker EC, Jui J, Chugh SS. Sudden cardiac death in patients with Type 1 versus Type 2 diabetes. Mayo Clin Proc. 2022;97:2271\u201381. https:\/\/doi.org\/10.1016\/j.mayocp.2022.05.021.","journal-title":"Mayo Clin Proc"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-023-01917-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12933-023-01917-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-023-01917-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,14]],"date-time":"2023-07-14T19:01:58Z","timestamp":1689361318000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiab.biomedcentral.com\/articles\/10.1186\/s12933-023-01917-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,14]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1917"],"URL":"https:\/\/doi.org\/10.1186\/s12933-023-01917-1","relation":{},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,14]]},"assertion":[{"value":"12 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"As a retrospective study using pseudo-anonymous routinely collected health data, informed consent was not obtained from participants according to Spanish regulations on observational studies. The study was approved by the Ethics Committee of the Primary Healthcare University Research Institute (IDIAP) Jordi Gol (Barcelona, Spain), approval number P17\/087 on 15\/03\/2017.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"No potential conflicts of interest relevant to this article were reported. The funders were not involved in the study design, data collection, data analysis, data interpretation, and writing of the report, and they did not impose any restrictions regarding the publication of the report. Prof. Mauricio is a co-author of this study and an Editorial Board member of the Cardiovascular diabetology journal. He was not involved in handling this manuscript during the submission and the review processes. The rest of the authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"179"}}